课题基金 / 基金详情

Enhancing the efficacy of Pseudomonas entomophila 23S, a PGPR for biocontrol of bacterial canker disease in tomato ******

Enhancing the efficacy of Pseudomonas entomophila 23S, a PGPR for biocontrol of bacterial canker disease in tomato ******
增强嗜虫假单胞菌 23S(一种用于生物防治番茄细菌性溃疡病的 PGPR)的功效 ******
批准号:
534001-2018
负责人:
Smith, Donald
金额:
$1.82万
依托单位:
依托单位国家:
加拿大
项目类别:
Engage Grants Program
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31

项目摘要

项目成果

Smith, Donald的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Bacterial canker disease, caused by Clavibacter michiganensis subsp. michiganensis (Cmm) is one of the most serious diseases of tomato. The disease has caused substantial crop losses and become a serious concern for both field and greenhouse tomato production in many parts of the world, including Canada. Existing control strategies, such as seed treatment and chemical control, have shown only limited efficacy in controlling this disease. Thus, effective control strategies are urgently required. The Smith laboratory at McGill University has discovered several strains that show antagonistic activity against Cmm, and an anti-Cmm compound produced by one of these strains, Pseudomonas sp. 23S was isolated. Given the seriousness of the disease damages, this anti-Cmm compound, as well as the producing stain is great potential as a new effective control strategy for tomato bacterial canker. Lallemand has been interested in developing a product to control Cmm and has been looking for potential approaches. With Lallemand's expertise on strain production, scale-up, formulation and product development, success in the proposed work would allow a full effort to completely understand the potential of a technology based on Pseudomonas sp. 23S and eventual full deployment in the Canadian context. We propose to study the anti- Cmm compounds produced by Pseudomonas sp. 23S and to determine the best production method. The project will consist of elucidating the minimum inhibitory concentration of the anti-Cmm compound, studying the concentration of the compound during various incubation phases, and examining the effects of Cmm on the production of anti- Cmm compounds produced by Pseudomonas sp. 23S. This work will improve the sustainability and economics of Canadian tomato producers and give them further leadership in the North American tomato production market. The work will provide a deeper understanding of the newly discovered anti-Cmm compound produced by Pseudomonas sp. 23S and its best production method, leading to a broader collaboration between Lallemand and McGill University; one that will allow further utilization of biologicals and the development of new products in agriculture.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Plant-microbe interactions: Understanding the signal loop for improved plant productivity
  • 批准号:
    RGPIN-2020-07047
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.4万
  • 财政年份:
    2022
  • 负责人:
    Smith, Donald
  • 依托单位:
Microbial consortia for enhanced and sustainable cannabis production
  • 批准号:
    557075-2020
  • 项目类别:
    Alliance Grants
  • 资助金额:
    $4.68万
  • 财政年份:
    2021
  • 负责人:
    Smith, Donald
  • 依托单位:
Plant-microbe interactions: Understanding the signal loop for improved plant productivity
  • 批准号:
    RGPIN-2020-07047
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.4万
  • 财政年份:
    2021
  • 负责人:
    Smith, Donald
  • 依托单位:
Enhanced yield and cannabinoid production of homogenous medical marijuana plants
  • 批准号:
    517552-2017
  • 项目类别:
    Collaborative Research and Development Grants
  • 资助金额:
    $11.66万
  • 财政年份:
    2020
  • 负责人:
    Smith, Donald
  • 依托单位:
国内基金
海外基金
噬菌体靶向肠道粪肠球菌提高帕金森病左旋多巴疗效的机制研究
  • 批准号:
    82371251
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    肖勤
  • 依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
  • 批准号:
    82370885
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨
  • 依托单位:
HER2特异性双抗原表位识别诊疗一体化探针研制与临床前诊疗效能研究
  • 批准号:
    82372014
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    魏伟军
  • 依托单位: